Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer.

Gong B, Pan J, Zhang J, Ren S, Tang Y, Jiang L

Open source

DOI
10.3390/molecules31040631
Published
2026 Feb 12
Container
Molecules (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/molecules31040631,
  title = {Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer.},
  author = {Gong B and Pan J and Zhang J and Ren S and Tang Y and Jiang L},
  year = {2026},
  journal = {Molecules (Basel, Switzerland)},
  doi = {10.3390/molecules31040631},
  url = {https://doi.org/10.3390/molecules31040631}
}

RIS

TY  - JOUR
TI  - Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer.
AU  - Gong B
AU  - Pan J
AU  - Zhang J
AU  - Ren S
AU  - Tang Y
AU  - Jiang L
PY  - 2026
JO  - Molecules (Basel, Switzerland)
DO  - 10.3390/molecules31040631
UR  - https://doi.org/10.3390/molecules31040631
ER  - 

APA

B, G., J, P., J, Z., S, R., Y, T., & L, J. (2026). Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer.. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules31040631

Source records